Pregled bibliografske jedinice broj: 665820
Extracellular signal-regulated kinase signalling in the hippocampus of a rat model of sporadic Alzheimer's disease
Extracellular signal-regulated kinase signalling in the hippocampus of a rat model of sporadic Alzheimer's disease // Periodicum biologorum
Zagreb, 2013. str. 77-77 (poster, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 665820 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Extracellular signal-regulated kinase signalling in the hippocampus of a rat model of sporadic Alzheimer's disease
Autori
Knezović, Ana ; Osmanović-Barilar, Jelena ; Riederer, Peter ; Šalković-Petrišić, Melita
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Periodicum biologorum
/ - Zagreb, 2013, 77-77
Skup
7th Croatian Congress of Pharmacology with international participation
Mjesto i datum
Zagreb, Hrvatska, 18.09.2013. - 21.09.2013
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
extracellular signal-regulated kinase; streptozotocin; Alzheimer's disease
Sažetak
Introduction: The pathogenesis of sporadic Alzheimer’s disease (sAD) has been associated with altered signalling in the mitogen-activated protein kinase (MAPK) pathways. The extracellular signal-regulated kinase (ERK), a MAPK subfamily member, was found activated in vulnerable cerebral neurons of sAD patients. We aimed to explore ERK signalling in the brain of streptozotocin (STZ)-intracerebroventricularly (icv) treated rats, a new experimental sAD model. Materials and methods: Three month-old male Wistar rats were injected intracerebroventricularly with STZ (3 mg/kg) or vehicle (controls). Cognitive functions were tested by Morris Water Maze Swimming Test before sacrifice, one and nine months following the STZ-icv treatment. Protein expression of phosphorylated and total tau protein (p-tau and t-tau) and pERK and tERK was measured in the hippocampus by SDS-PAGE electrophoresis, followed by immunoblotting. Data were analysed by Mann-Whitney U test (p<0.05). Results: One month after the STZ-icv treatment only protein expression of pERK was found significantly increased (+23%). Signalling dysfunction progressed up to 9 months after the STZ-icv treatment when further significant increment in pERK expression (+38%) accompanied by decreased t-ERK expression (-20%) was found followed by increased p/t-tau ratio (+39% ; p=0.08). Cognitive deficits of STZ-icv treated rats were present at both time-points (-30% and -39%). Conclusion: STZ-induced activation of hippocampal ERK pathway, known to be involved in cellular responses to pro-inflammatory signals, supports the similarity of inflammatory processes found in the brain of STZ-icv model and sAD patients. Presented results provide further evidence of STZ-icv rat model being a representative sAD model. Acknowledgment: Supported by MZOŠ and DAAD.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb